Asset Publisher

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Photo: Mattias Bronge, Karolinska Institutet

A validation project of new SARS-CoV-2 antibody tests, headed by Associate Professor Anna Fogdell-Hahn is supported with SEK 4 157 000 from Swelife, a strategic innovation programme, funded by the Swedish Government via the Swedish innovation agency, Vinnova, and by the programme’s partners.

The project started as a response to the pandemic at CMM in the lab of Anna Fogdell-Hahn’s Group and it will continue until June 2021. Anna has a long experience in studying antibody responses against biological  drugs (so called anti-drug antibodies), a side effect of biopharmaceutical treatments used for instance in patients with autoimmune diseases. Another research focus is the involvement of virus infections in autoimmune diseases. Both areas of technical expertise are useful in the context of SARS-CoV-2 serology, so Anna and her research Group re-structured their lab in order to start a project and contribute to fighting the Pandemic.

This funded project provides an independent verification of the sensitivity and specificity of commercial SARS-CoV-2 antibody tests , as a complement to other validation methods. In this way, the process can be accelerated and the tests become available on the market faster. This will contribute to facilitate larger scale SARS-CoV-2 antibody tests on the whole population without increasing the burden of the public health care system. The project also makes a long-term study of immunity to SARS-CoV-2 possible by following up the patients who tested positive for antibodies.

 

An interview with Anna Fogdell-Hahn and a more detailed description of the project can be found in Swedish on the Swelife website:

https://swelife.se/2020/07/31/nytt-projekt-verifierar-serologitester/

https://swelife.se/projekt/antikroppar-mot-sars-cov-2/

NEWS

Ning Xu Landén 2020 year’s winner of the LEO Foundation Award

Ning Xu Landén 2020 year’s winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system Photo: Hans Ericksson, SSMF Nils Landegren , Researcher at CMM, has been awarded...

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife Photo: Mattias Bronge, Karolinska Institutet A validation project of new SARS-CoV-2 antibody tests,...

Grant to Qiaolin Deng for the single-cell technology core at CMM

Grant to Qiaolin Deng for the single-cell technology core at CMM Qiaolin Deng, private photo We congratulate Associate Professor and CMM Team Leader Qiaolin Deng who received a SFO...

Identification of key gene for improvement of multiple sclerosis treatments

Identification of key gene for improvement of multiple sclerosis treatments Karl Carlström and Fredirk Piehl. Photo: Stefan Zimmermann   CMM researcher Karl Carlström and...

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million Sweden’s innovation agency Vinnova extends the funding of the national...

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius Professor Marie Wahren-Herlenius, Group Leader at CMM, has received the biggest yearly grant in Sweden...

Simple blood test may help predict MS progression, study finds

Simple blood test may help predict MS progression, study finds Photo: Ali Manouchehrinia   A study led by the CMM researchers Ali Manouchehrinia (first...

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis   Karl Carlström, photo Stefan Zimmerman   Karl...

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows A study made by Philippe Melas from Karolinska Institutet together with colleagues at Columbia...